InsiderCHIEF EXECUTIVE OFFICER

Grant Pickering Insider Trading Activity

Every SEC Form 4 transaction reported by Grant Pickering, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Grant Pickering buying or selling?

Grant Pickering reported 1 open-market buys ($60.4K) and 57 sells ($39.1M) across 58 Form 4 filings at 2 companies — a net selling position of $39.0M.

Source: SEC EDGAR Form 4

What stands out

  • Grant Pickering has reported Form 4 transactions at 2 companies; the most active, Vaxcyte, Inc. (PCVX), accounts for 57 of 58 filings (98%).
  • The most recent Form 4 was accepted on Jul 28, 2026 (2 months ago).
  • In the last 12 months: no open-market purchases and 3 sales ($3.6M).
  • The largest open-market sale in the last 12 months was $1.3M of Vaxcyte, Inc. (PCVX) on Jun 26, 2026. SEC ↗

Key Statistics (as of Jul 28, 2026)

Total Form 4 filings
58
SEC EDGAR
Companies
2
Buys (1)
$60.4K
Sells (57)
$39.1M

Insider sentiment

Net selling

Net insider flow of $39.0M in net selling, filed between Dec 23, 2020 – Jul 28, 2026.

Companies Grant Pickering files for

#CompanyForm 4 filings
1PCVXVaxcyte, Inc.57
2LONAAthira Pharma, Inc.1

Recent Grant Pickering transactions

DateTickerRoleTypeSharesValueFiling
Jul 28, 2026PCVXCHIEF EXECUTIVE OFFICERSale18.2K$1.0MSEC ↗
Jun 26, 2026PCVXCHIEF EXECUTIVE OFFICERSale24.2K$1.3MSEC ↗
Jun 19, 2026PCVXCHIEF EXECUTIVE OFFICERSale24.5K$1.3MSEC ↗
Dec 10, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.4K$218.3KSEC ↗
Dec 4, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.4MSEC ↗
Nov 9, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.4K$245.8KSEC ↗
Nov 4, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.6MSEC ↗
Oct 9, 2024PCVXCHIEF EXECUTIVE OFFICERSale7.1K$775.2KSEC ↗
Oct 3, 2024PCVXCHIEF EXECUTIVE OFFICERSale55.0K$6.3MSEC ↗
Aug 26, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.2MSEC ↗
Aug 5, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$206.1KSEC ↗
Jul 24, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.3MSEC ↗
Jul 2, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$199.7KSEC ↗
Jun 25, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.1MSEC ↗
Jun 5, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$188.5KSEC ↗
May 28, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.0MSEC ↗
May 3, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$161.4KSEC ↗
Apr 25, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$928.8KSEC ↗
Apr 3, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$174.5KSEC ↗
Mar 27, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$1.0MSEC ↗
Mar 5, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$192.8KSEC ↗
Feb 27, 2024PCVXCHIEF EXECUTIVE OFFICERSale45.0K$3.5MSEC ↗
Feb 5, 2024PCVXCHIEF EXECUTIVE OFFICERSale2.6K$193.4KSEC ↗
Jan 31, 2024PCVXCHIEF EXECUTIVE OFFICERSale30.0K$2.0MSEC ↗
Jan 25, 2024PCVXCHIEF EXECUTIVE OFFICERSale15.0K$958.8KSEC ↗

Showing the 25 most recent filings of 58. Screen every filing.

Grant Pickering insider trading FAQ

Is Grant Pickering buying or selling?

Across 58 SEC Form 4 filings, Grant Pickering reported 1 open-market purchases totaling $60.4K and 57 sales totaling $39.1M — a net selling position of $39.0M.

Which companies does Grant Pickering file Form 4s for?

Grant Pickering has reported insider transactions at 2 companies, most often Vaxcyte, Inc. (PCVX), Athira Pharma, Inc. (LONA).

How far back does Grant Pickering's filing history go?

Trabud holds Grant Pickering's SEC Form 4 filings from Dec 23, 2020 – Jul 28, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Grant Pickering's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Grant Pickering and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener